MEGAPLAT 50MG INJECTION
Oxaliplatin 50 mg
Alkem Laboratories
It available as a solution for injection, to be administered by a healthcare provider into the vein.
Intravenous: Store intact vials at 15-30°C; do not freeze. Reconstituted solution: May store at 2-8°C for up to 24 hr. Diluted solutions: Stable up to 6 hr at 20-25°C or up to 24 hr under refrigeration at 2-8°C.
Pregnancy Peripheral neuropathy with functional impairment Severe renal impairment.
Alzheimer's disease : Alzheimer's disease is a neurological disorder in which the death of brain cells causes memory loss and cognitive decline. A neurodegenerative type of dementia, the disease starts mild and gets progressively worse. And it is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death. Drugs has too little role in the management of Alzheimer’s disease No medication has been clearly shown to delay or halt the progression of the disease. Drugs used are • Acetylcholinesterase inhibitors – Donepezil, Galantamine, Rivastigmine • NMDA-receptor (N-Methyl-D-aspartate receptor) antagonist -Memantine
May decrease plasma levels of digoxin. May increase risk of toxicity with nephrotoxic drugs. When administered as sequential infusions, taxane derivatives (docetaxel, paclitaxel) should be administered before oxaliplatin to limit myelosuppression and enhance efficacy.
Whether you're looking for a doctor for dealing with your own medical condition, click here to find right physician.
It is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant.